Y. Tadayasu, “Population Pharmacokinetic/Pharmacodynamic Analysis of the DPP-4 Inhibitor Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus”, J Pharm Pharm Sci, vol. 16, no. 5, pp. 708–721, Dec. 2013.